Teva Pharmaceuticals USA, Inc. v. Doctor Reddy's Laboratories Ltd.
1:15-cv-00306
Overview
Parties
Defendant
Amneal Pharmaceuticals Company NPE (Individual / Inventor)
Represented By
0 Attorneys ListedAmneal Pharmaceuticals LLC Operating Company
Represented By
0 Attorneys ListedSynthon Pharmaceuticals Inc. Operating Company
Represented By
0 Attorneys ListedMomenta Pharmaceuticals Inc. Operating Company
Represented By
1 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
300 Delaware Avenue, Suite 200, Wilmington, DE 19801
Sandoz Inc. Operating Company
Represented By
1 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
300 Delaware Avenue, Suite 200, Wilmington, DE 19801
Mylan Pharmaceuticals Inc. Operating Company
Represented By
0 Attorneys ListedDoctor Reddy's Laboratories Inc. Operating Company
Represented By
0 Attorneys ListedDoctor Reddy's Laboratories Ltd. Operating Company
Represented By
0 Attorneys ListedPlaintiff
Yeda Research and Development Co., Ltd. Operating Company
Represented By
4 Attorneys ListedGould & Ratner LLP
222 N. LaSalle Street, Suite 800
Bayard, P.A.
Bayard, P.A., 600 N. King Street
ADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 655-5000
Teva Neuroscience Inc Operating Company
Represented By
4 Attorneys ListedGould & Ratner LLP
222 N. LaSalle Street, Suite 800
Bayard, P.A.
Bayard, P.A., 600 N. King Street
ADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 655-5000
Teva Pharmaceutical Industries Ltd Operating Company
Represented By
4 Attorneys ListedGould & Ratner LLP
222 N. LaSalle Street, Suite 800
Bayard, P.A.
Bayard, P.A., 600 N. King Street
ADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 655-5000
Teva Pharmaceuticals USA, Inc. Operating Company
Represented By
4 Attorneys ListedGould & Ratner LLP
222 N. LaSalle Street, Suite 800
Bayard, P.A.
Bayard, P.A., 600 N. King Street
ADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 655-5000
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 16 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8969302
Low frequency glatiramer acetate therapy
|
Filed: 2013-02-19
Issued: 2015-03-03
|
Active (6.3 yrs remaining)
Expires: 2033-02-19
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked.